RevBio Secures 10th Patent for TETRANITE®: Expanding Protection for Revolutionary Bone Adhesive Technology In a significant milestone for regenerative medicine, ITS, a clinical-stage medical device company, has been granted its 10th U.S. patent for its groundbreaking TETRANITE® bone adhesive technology.…
The global Pharmaceutical R&D Outsourcing market is set to grow significantly, with a valuation of USD 84.01 billion in 2023 and expected to reach USD 150.04 billion by 2029, representing a compound annual growth rate (CAGR) of 10.15%. This growth…
Modella AI, a leader in generative and agentic artificial intelligence for biomedicine, has announced that its advanced generative AI co-pilot, PathChat DX, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This prestigious recognition highlights…
Trilobio Unveils Revolutionary Whole-Lab Automation Platform at SLAS2025: A Game-Changer for Life Science Research San Diego, CA – January 25-29, 2025 – Trilobio, a pioneering developer of whole-laboratory automation solutions, is set to make waves at the Society for Laboratory…
Inventia Life Science Unveils RASTRUM™ Allegro to Transform 3D Cell Culture in Drug Discovery and Disease Research Inventia Life Science, a leader in 3D cell culture technologies, has announced the launch of RASTRUM™ Allegro, a revolutionary platform that enhances drug…
Genentech Announces Positive OS Results for Itovebi in Advanced HR-Positive Breast Cancer Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), has announced positive topline results from the Phase III INAVO120 study investigating the combination of Itovebi™…
Cannabis Pharmaceuticals Market 2024-2034: Focus on Sativex, Cesamet, Marinol, Epidiolex – ResearchAndMarkets.com The global cannabis pharmaceuticals market, valued at USD 3.46 billion in 2023, is expected to experience remarkable growth, reaching USD 380.77 billion by 2034. This expansion is forecasted…
Salubris Biotherapeutics Announces Positive Interim Data from Phase 2 Trial of JK07 in Heart Failure Salubris Biotherapeutics a clinical-stage biotechnology company focused on developing innovative biologic therapies, has announced promising interim data from its Phase 2 clinical trial of JK07…
BrainChild Bio Receives Recognition for Innovation in Cell Therapy ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation, and CellReady, has announced that BrainChild Bio has been awarded a $300,000 G-Rex® Grant. This prestigious grant is aimed at accelerating the…
WHO Expresses Regret Over U.S. Withdrawal Announcement The World Health Organization (WHO) has expressed deep regret over the announcement that the United States intends to withdraw from the Organization. The decision, if finalized, would mark a significant shift in global…
Poxel Achieves Milestone with TWYMEEG® Sales in Japan, Secures Royalties and Sales-Based Payments Poxel, a clinical-stage biopharmaceutical company focused on innovative treatments for chronic serious diseases with metabolic pathophysiology—including metabolic dysfunction-associated steatohepatitis (MASH) and rare metabolic disorders—has announced a significant…
UCB is A global biopharmaceutical leader committed to improving the lives of people living with severe diseases, highlighted its decade of growth and strategic priorities at the 43rd J.P. Morgan Healthcare Conference in San Francisco. For nearly a century, It…
